Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (137)
  2. Journal Article (95)
  3. Book Section (8)
  4. Review (6)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (250)
  2. Department of Medicine (250)
  3. Solid Tumor Oncology Division (250)
  4. Survivorship Research (250)
  5. Epidemiology and Biostatistics (99)
  6. Biostatistics Service (85)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (3)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (76)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (77)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (16)
  6. Future Medicine (5)

More Publishers

Results (250)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cognitive impairment in older patients with breast cancer before systemic therapy: Is there an interaction between cancer and comorbidity?
    Journal Article

    Mandelblatt, J. S.; Stern, R. A.; Luta, G.; McGuckin, M.; Clapp, J. D.; Hurria, A.; Jacobsen, P. B.; Faul, L. A.; Isaacs, C.; Denduluri, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tolerability of chemotherapy in HIV-infected women with breast cancer: Are there prognostic implications?
    Journal Article

    Parameswaran, L.; Taur, Y.; Shah, M. K.; Traina, T. A.; Seo, S. K.
    AIDS Patient Care and STDs (2014)

    Fulltext@MSK | Save
  • A phase 1 open-label study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide alone or combined with an aromatase inhibitor in women with advanced breast cancer
    Meeting Abstract

    Traina, T. A.; Yardley, D. A.; Patel, M. R.; Schwartzberg, L. S.; Elias, A.; Gucalp, A.; Blaney, M. E.; Gibbons, J.; Hudis, C. A.; LoRusso, P.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide (previously MDV3100) alone or in combination with an aromatase inhibitor in women with advanced breast cancer
    Meeting Abstract

    Traina, T. A.; Yardley, D. A.; Patel, M.; Schwartzberg, L.; Elias, A.; Gucalp, A.; Peterson, A. C.; Hannah, A.; Gibbons, J.; Khondker, Z.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer
    Meeting Abstract

    Traina, T. A.; O'Shaughnessy, J.; Kelly, C.; Schwartzberg, L.; Gucalp, A.; Peterson, A.; Bhattacharya, S.; Trudeau, M.; Hudis, C. A.; Schmid, P.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Significance of circulating tumor cells in metastatic triple negative breast cancer: Results of an open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 tigatuzumab (TBCRC 019)
    Meeting Abstract

    Paoletti, C.; Li, Y.; Muñiz, M. C.; Kidwell, K. M.; Aung, K.; Thomas, D. G.; Brown, M. E.; Abramson, V.; Irvin, W. J. Jr; Lin, N. U.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Understanding triple-negative breast cancer
    Book Section

    Gucalp, A.; Traina, T. A.
    In Ahmad, A. (Eds.) Breast Cancer Metastasis and Drug Resistance: Progress and Prospects (2013)

    Fulltext@MSK | Save